Based on the earnings transcript, Amgen Inc. reported strong financial results for the third quarter of 2013, with revenue growth of 11% and earnings per share growth of 16%. The company also raised its full-year guidance for revenue and adjusted earnings per share. Management highlighted several strategic priorities, including the launch of new products and the expansion of the company's presence in key markets. However, the stock market is likely to face short-term pressure due to tempered guidance and uncertainties around key defense contracts.